Table 2 mRNA sequencing datasets containing overall survival and progress free interval of serous ovarian patients treated with Taxol
From: High expression of RIPK2 is associated with Taxol resistance in serous ovarian cancer
Accession number of dataset | Platform | Pathological type | Samples treated with Taxol |
|---|---|---|---|
GSE30161 | GPL570 | serous cancer (85%) | 58 |
GSE32063 | GPL6480 | advanced-stage high-grade serous ovarian cancer | 40 |
GSE63885 | GPL570 | serous cancer | 36 |